Sign in

CIK 0000310158

  • Large accelerated filer

Merck & Co., Inc.

Sign in to watch
Ticker
MRK
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NJ
Entity type
Operating
EIN
221918501
Phone
+1 908-740-4000
Business address
126 EAST LINCOLN AVENUE, P.O. BOX 2000, RAHWAY, NJ, 07065
Former names
Merck & Co. Inc., SCHERING PLOUGH CORP
  1. 4 Grant or award SVP Fin. - Global Controller acquired 2,586 shares (grant or award)
  2. 4 Grant or award President, U.S. Market acquired 8,664 shares (grant or award)
  3. 4 Grant or award EVP & CFO acquired 23,432 shares (grant or award)
  4. 4 Grant or award Executive VP & President, MRL acquired 32,621 shares (grant or award)
  5. 4 Grant or award Chief Comm. & Public Afrs Ofcr acquired 9,446 shares (grant or award)
  6. 4 Grant or award EVP&Pres, Merck Animal Heallth acquired 25,438 shares (grant or award)
  7. 4 Grant or award Chairman, CEO & President acquired 95,275 shares (grant or award)
  8. 4 Grant or award Exe V-P & Pres. MMD acquired 28,136 shares (grant or award)
  9. 4 Grant or award Chief Marketing Officer acquired 28,158 shares (grant or award)
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 3 Insider Initial Statement of Ownership
  15. 3 Insider Initial Statement of Ownership
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Exercise or conversion Chief Marketing Officer acquired 36,901 shares (option exercise)
  20. 4 Derivatives Options or other derivatives

Page 8 of 99 · 1,973 filings